Matinas BioPharma Holdings Inc (FRA:6LJ0)
€ 2.69 0 (0%) Market Cap: 3.23 Mil Enterprise Value: -7.02 Mil PE Ratio: 0 PB Ratio: 0.15 GF Score: 57/100

Matinas BioPharma Holdings Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 09, 2021 / 09:45PM GMT
Release Date Price: €45.25
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

Good afternoon, everyone. My name is Balaji Prasad. I'm the spec pharma analyst for Barclays. And continuing on with our Global Healthcare Conference on the spec pharma track for the last meeting of the day -- of today, I'm pleased to introduce you to Jerry Jabbour, President and CEO of Matinas BioPharma. There's -- the format is going to be a presentation from Jerry's side. And so with that, Jerry, I invite you to take over.

Jerome D. Jabbour
Matinas BioPharma Holdings, Inc. - Co-Founder, CEO, President & Director

Great. Balaji, thank you very much. We're so grateful for the opportunity to present today at the Barclays Conference. We're happy to be the last meeting of the day. We know it's been a long day for investors. But we're thrilled for this to have the opportunity to present on this platform. It's been an exciting beginning to 2021 for us, and we believe the invitation to speak at the Barclays Global Healthcare Conference is really indicative of the progress we've made as a company.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot